Clínica Baviera Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	304.91	265.72	227.07	198.45	173.25
Revenue Growth (YoY)	14.75%	17.02%	14.42%	14.55%	41.28%
Cost of Revenue	153.93	133.18	115.1	96.55	84.05
Gross Profit	150.98	132.54	111.97	101.9	89.2
Selling, General & Admin	-	13.93	12.09	11.69	9.87
Amortization of Goodwill & Intangibles	-	-	-	15	-
Other Operating Expenses	66.44	42.08	32.86	33.25	25.77
Operating Expenses	90.34	76.89	61.93	59.94	49.73
Operating Income	60.64	55.65	50.04	41.96	39.46
Interest Expense	-2.28	-1.22	-0.57	-0.42	-0.46
Interest & Investment Income	1.52	0.3	0.15	0.07	0
Earnings From Equity Investments	0.04	-0.02	-0.01	-0.06	-0.03
Currency Exchange Gain (Loss)	-0.08	0.04	0.01	-0	-0
Other Non Operating Income (Expenses)	0.37	1.22	0.07	-0.4	-0.04
EBT Excluding Unusual Items	60.21	55.96	49.68	41.15	38.93
Asset Writedown	-0.1	0.03	-0.03	-0.47	-0.03
Pretax Income	60.11	55.99	49.65	40.68	38.9
Income Tax Expense	17.18	14.86	12.92	10.53	10.97
Earnings From Continuing Operations	42.94	41.14	36.73	30.15	27.93
Minority Interest in Earnings	-0.87	-0.93	-0.76	-0.63	-0.54
Net Income	42.06	40.21	35.97	29.52	27.39
Net Income to Common	42.06	40.21	35.97	29.52	27.39
Net Income Growth	4.62%	11.77%	21.86%	7.77%	96.46%
Shares Outstanding (Basic)	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16
Shares Change (YoY)	1.89%	-1.85%	-	-	0.01%
EPS (Basic)	2.58	2.51	2.21	1.81	1.68
EPS (Diluted)	2.58	2.51	2.21	1.81	1.68
EPS Growth	2.68%	13.88%	21.86%	7.77%	96.43%
Free Cash Flow	46.47	36	35.13	39.35	36.28
Free Cash Flow Per Share	2.85	2.25	2.15	2.41	2.23
Dividend Per Share	-	1.570	1.570	1.300	1.030
Dividend Growth	-	-	20.77%	26.21%	86.59%
Gross Margin	49.52%	49.88%	49.31%	51.35%	51.49%
Operating Margin	19.89%	20.94%	22.04%	21.14%	22.78%
Profit Margin	13.79%	15.13%	15.84%	14.88%	15.81%
Free Cash Flow Margin	15.24%	13.55%	15.47%	19.83%	20.94%
EBITDA	84.54	75.63	66.5	56.76	53.35
EBITDA Margin	27.73%	28.46%	29.29%	28.60%	30.80%
D&A For EBITDA	23.9	19.98	16.46	14.8	13.89
EBIT	60.64	55.65	50.04	41.96	39.46
EBIT Margin	19.89%	20.94%	22.04%	21.14%	22.78%
Effective Tax Rate	28.57%	26.53%	26.02%	25.89%	28.19%
Advertising Expenses	-	12.14	10.31	9.86	8.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.